NEW YORK (GenomeWeb News) – In Nature Genetics, two teams described the immune region-focused, Immunochip array-based strategy that they used to find sites in the genome with ties to a serious liver disease called
NEW YORK (GenomeWeb News) – Targets of the FOXP2 transcription factor appear to be under strong, positive selective pressure in European populations, researchers led by the Wellcome Trust Sanger Institute's Chris Tyler-Smith reported in an online, early American Journal of Human Genetics
NEW YORK (GenomeWeb News) – The Wellcome Trust Sanger Institute has launched an online survey to collect the views of "ordinary people" about how personal genomic information should be used in medical research and by agencies
NEW YORK (GenomeWeb News) – Two new Nature Genetics studies suggest that mutations affecting a gene called SMIM1 are behind the rare "Vel" blood group — named for the lack of Vel antigen expression on red blood cells of those affected.
Using a combination of immunomagnetic separation and multiple displacement amplification, or IMS-MDA, a team led by researchers at the Wellcome Trust Sanger Institute has developed a method allowing sequencing of whole genomes from discarded molecular diagnostics samples, without
NEW YORK (GenomeWeb News) – Blueprint Medicines today announced a collaboration with Wellcome Trust Sanger Institute and the Massachusetts General Hospital Cancer Center to identify new cancer targets.
NEW YORK (GenomeWeb News) – Tapeworm infections may be vulnerable to some of the same compounds used in cancer chemotherapy — at least that's one of the predictions stemming from a new Nature study focused on genome sequences for four tapeworm species.